Philippine’s research panel for vaccine is now looking into Russia’s report on its registered coronavirus vaccine “Sputnik V” to ascertain it is safe for Filipino’s clinical testing.
Department of Science and Technology-Philippine Council for Health Research and Development, Executive Director Dr. Jaime Montoya confirmed that they have received detailed reports on the Phase 1 and 2 of said Russian-produced vaccine.
A comprehensive review of these documents will be conducted to ensure safety and efficacy of the vaccine before the Philippines can move a step closer to holding the Phase 3 in the country.
“They will be releasing their evaluation hopefully by next week,” Montoya said in a text message.
Health spokesperson Maria Rosario Vergeire added the Philippines has yet to finalize several legal documents for the trial, such as the confidentiality disclosure agreements.
The Food and Drug Administration must approve the conduct of trials before it can be started in the Philippines.
Once it is approved, around 1,000 healthy participants from the Philippines will participate the Phase 3. This crucial phase is required before the FDA reviews the vaccine for mass vaccination.
